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Mammalian thioredoxin reductase (TR) is a pyridine nucleotide disulfide oxidoreductase that uses the rare amino acid selenocysteine (Sec, U) in place of the more commonly used amino acid cysteine (Cys) in its catalysis of the reduction of its major target protein, thioredoxin (Trx), and a variety of small molecule substrates.^[@ref1]−[@ref10]^ The thioredoxin system, comprised of TR, Trx, and NADPH, is one of the major antioxidant systems in mammalian cells.^[@ref9]^

The use of a selenium (Se) atom in place of a sulfur (S) atom in TR and other selenoenzymes is most likely due to important physicochemical differences between the two residues and confers some biological advantage to the organism containing the selenoenzyme. The physicochemical advantage given to an enzyme that uses Sec instead of Cys is the subject of ongoing debate in the field.^[@ref11]−[@ref13]^ Most selenoenzymes studied to date are oxidoreductases that are involved in thiol/disulfide exchange reactions in which Sec replaces Cys. In such cases, the presence of selenium in the form of a selenolate or selenosulfide can accelerate the rate of the exchange reaction by being (i) a better nucleophile than a thiolate, (ii) a better electrophile than a disulfide, (iii) a better leaving group than a thiolate, or (iv) a more chemically reactive species compared to sulfur in the form of a thiolate or disulfide using a combination of all three of these factors.

Selenocysteine participates in the reaction mechanism of TR in two key thiol/disulfide exchange reactions as shown in Figure [1](#fig1){ref-type="fig"}. First, the selenolate of Sec acts as the donor of electrons to the substrate, the disulfide bond of Trx (Figure [1](#fig1){ref-type="fig"}A), and second, as part of the selenosulfide bond found in the C-terminus of the enzyme, selenium takes part in accepting electrons from the N-terminal redox center of TR (Figure [1](#fig1){ref-type="fig"}B). It is well-established that selenols and selenolates are better nucleophiles than are thiols and thiolates,^[@ref15]−[@ref18]^ and because Sec was first discovered in TR, the selenolate has been the presumptive nucleophile for the initial attack on a substrate disulfide bond in the TR mechanism.^[@ref15]^ Experimental evidence of this includes a large decrease in reaction velocity when Sec is replaced by Cys,^[@ref15],[@ref19],[@ref20]^ as well as recent crystallographic data in which TR was crystallized in a mixed disulfide complex with a mutant form of human Trx1 (hTrx1).^[@ref21]^ In this latter experiment, the C-terminal Cys~497~-Sec~498~ redox dyad was mutated to a Ser~497~-Cys~498~ dyad, and this TR mutant was incubated with the C35S/C73S mutant of hTrx1. The result was a mixed disulfide-bonded complex between Cys498 of human TR (hTR) and Cys32 of hTrx1. This is strong evidence that Sec498 of hTR in the wild-type (WT) enzyme is the attacking nucleophile in thiol/disulfide exchange reactions involving substrates such as the one shown in Figure [1](#fig1){ref-type="fig"}A.

![Mechanistic roles of Se in the TR reaction mechanism as a donor or acceptor of electrons. In the TR reaction mechanism, electrons flow from NADPH to the enzyme-bound flavin. The reduced flavin coenzyme then reduces the N-terminal redox center, consisting of Cys~CT~ and Cys~IC~ (colored green). Cys~IC~ then attacks the selenosulfide bond of the C-terminal Cys-Sec dyad, forming either a mixed disulfide (path 1) or a mixed selenosulfide (path 2). Cys~CT~ then resolves the mixed disulfide/selenosulfide, re-forming the N-terminal disulfide between Cys~CT~ and Cys~IC~. For a complete description of the mechanism, please see ref ([@ref14]). Two equivalents of NADPH are required to produce the active EH~4~ form. The EH~4~ form is the active form of the enzyme that reduces Trx as shown by Williams and co-workers.^[@ref14]^ (A) Se donates electrons to Trx in an initial nucleophilic attack step. The individual rate constant for this step is given as *k*~Nuc-Se~. (B) Se can accelerate the thiol/disulfide exchange step that occurs between the two reaction centers either by acting as a good leaving group (arrow 1) or by acting as a good electrophile (arrow 2). The individual rate constant for this step is given as *k*~ex~. Mutating Sec to Cys may impair the enzyme's ability to either donate or accept electrons as discussed in the text.](bi-2013-00658g_0002){#fig1}

After reducing its substrate, the C-terminal Cys-Sec dyad of TR becomes oxidized and forms an eight-membered ring structure (Figure [1](#fig1){ref-type="fig"}B). This vicinal selenosulfide bond then undergoes another thiol/disulfide exchange reaction with the N-terminal redox center that is composed of an interchange Cys residue (Cys~IC~) and a charge-transfer Cys (Cys~CT~) residue that interacts with the flavin coenzyme. As explained in the legend of Figure [1](#fig1){ref-type="fig"}B, the thiolate of Cys~IC~ can attack either the sulfur (path 1) or the selenium (path 2) of the selenosulfide bond. Unlike the thiol/disulfide exchange step involving Trx, there is no X-ray crystal structure of a trapped mixed disulfide intermediate between the C-terminal redox center and the N-terminal redox center. Attempts have been made to model this thiol/disulfide exchange step in crystal structures of various high-*M*~r~ TR enzymes.^[@ref22]−[@ref24]^ These studies are inconclusive because they show that either path 1 or path 2 is a feasible route of attack *depending* on how the C-terminus is modeled into the active site.

In our early work, we had argued for path 1 because of the belief that the selenolate of Sec would act as a superior leaving group in this exchange reaction.^[@ref24],[@ref25]^ Path 1 can thus be described as a "Se as a leaving group" model. Later, we began to favor path 2, which involves attack at the selenium of the selenosulfide by Cys~IC~, and this can be described as the "Se as an electrophile" model. This model was supported by experimental data that showed that the truncated TR, missing the C-terminal tail, would only reduce highly electrophilic, small molecule substrates, irrespective of whether they contained a low-p*K*~a~ leaving group.^[@ref6],[@ref26]^ This model is also supported by recent theoretical and experimental studies that show that attack at the selenium in a selenosulfide is highly favored over attack at the sulfur in thiol/disulfide exchange reactions.^[@ref27],[@ref28]^ The high electrophilicity of selenide relative to that of sulfide has been recognized in the field of chemistry^[@ref29]^ but is a largely unrecognized property in the biochemical literature.

In this report, we resolve the question of attack at Se or S in a selenosulfide by performing Br`ø`nsted analyses of synthetic, disulfide-containing substrates in which the p*K*~a~ of the leaving group thiol was varied by changing the substituent at the *para* position of the aromatic ring. In addition, we have constructed a mutant of TR with either a single Sec residue or a single sulfhydryl group in place of the Cys-Sec redox dyad in the C-terminal redox center. The data from these mutants show that the second position of the C-terminal redox dyad, occupied by a Sec residue, is responsible for both donating electrons to Trx and accepting them (from Cys~IC~, path 2) in the thiol/disulfide exchange reaction that occurs between the N- and C-terminal redox centers. The results reported here highlight how the enzyme can use selenium to accelerate thiol/disulfide exchange reactions.

Materials and Methods {#sec2}
=====================

Materials {#sec2.1}
---------

NADPH was purchased from AppliChem (Darmstadt, Germany). Dithionitrobenzoic acid (DTNB), sodium selenite, and DEAE resin were all obtained from Sigma-Aldrich (St. Louis, MO). Phenyl Sepharose resin was from Pharmacia-Amersham Biosciences (Uppsala, Sweden). Microcon Ultracel YM-50 ultrafiltration devices from Millipore (Billerica, MA) were used for concentrating enzyme samples. Resin for peptide synthesis (2-chlorotritylchloride) was from Novabiochem (San Diego, CA). Fmoc amino acids were from Synbiosci Corp. (Livermore, CA), except for Fmoc-homocysteine, which was from Bachem (King of Prussia, PA). Primers for mTR3 mutants were from IDT (Coralville, IA). Plasmid pTYB3 and restriction enzymes were from New England Biolabs (Ipswich, MA). The production and purification of the recombinant and semisynthetic enzymes used in this study have been previously reported.^[@ref6],[@ref19],[@ref24],[@ref25],[@ref30]^ The selenium content of the wild-type (WT) semisynthetic enzyme is 91% as reported in ref ([@ref19]). Enzyme kinetic assays were performed on a Cary50 UV--vis spectrophotometer (Walnut Creek, CA), and all enzymatic assays were conducted at room temperature unless otherwise noted. All other chemicals were from Fisher Scientific or Acros Organics (Morris Plains, NJ). Aryl disulfides were prepared by Watson Lees and others as described in refs ([@ref31]−[@ref35]).

Peptide Synthesis {#sec2.2}
-----------------

All peptides in this study were synthesized on 2-chlorotritylchloride resin using standard Fmoc chemistry as previously detailed.^[@ref19],[@ref25],[@ref36]^ Peptides were cleaved from the resin using trifluoroacetic acid (TFA) containing triisopropylsilane and water in a 96:2:2 ratio. The cleavage volume was reduced by evaporation under a stream of N~2~ or air, and the peptides were then precipitated in ice-cold diethyl ether. Once dry, the peptides were redissolved in a 90:10 (v/v) water/acetonitrile mixture and lyophilized. The freeze-dried peptide was then analyzed by both MALDI-TOF mass spectrometry and analytical HPLC to judge the composition and purity.

Peptides **I--IV** (Table [1](#tbl1){ref-type="other"}) containing a mixed aryl disulfide bond were constructed by first synthesizing a peptide corresponding to the sequence of the C-terminus of mTR, with the Sec residue replaced with a Gly residue (H-PTVTGCGG-OH). This peptide and a *para*-substituted aryl disulfide compound (1:3 molar ratio) were dissolved in 50 mM potassium phosphate buffer (pH 8.0), and then the mixture was stirred at room temperature for 16 h. Peptides **I--IV** were isolated by HPLC, analyzed by MALDI-TOF MS, and lyophilized for later use.

###### Activity of mTRΔ8 toward Mammalian Peptide-Aryl Disulfide Substrates

![](bi-2013-00658g_0009){#fx1}

Taken from ref ([@ref38]).

Taken from ref ([@ref39]).

Taken from ref ([@ref40]).

Taken from ref ([@ref41]). The data reported here for peptides **V**--**VIII**and **DTNB** was taken from ref ([@ref25]).

Production of Recombinant and Semisynthetic Mutants of Mouse Mitochondrial TR (mTR3) {#sec2.3}
------------------------------------------------------------------------------------

A brief description of the nomenclature used in Tables [2](#tbl2){ref-type="other"} and [3](#tbl3){ref-type="other"} (and throughout) is warranted here. The C-terminal redox-active tetrapeptide of mTR3 contains the amino acids H-Gly-Cys-Sec-Gly-OH. In Table [2](#tbl2){ref-type="other"}, we abbreviate the main body of the enzyme as mTR3 and the C-terminal tetrapeptide as GCUG. Thus, the WT enzyme is abbreviated as mTR3-GCUG throughout this report. Mutants are abbreviated as mTR3-aa~1~aa~2~aa~3~aa~4~ (using one-letter codes for the amino acids). The production of both the full-length WT enzyme and semisynthetic mutant enzymes by intein-mediated peptide ligation (IPL) has been previously described.^[@ref19]^ Briefly, mTR3 missing the final three C-terminal residues (mTR3Δ3) is expressed as an intein--chitin binding domain (CBD) fusion protein in *Escherichia coli* cells and then bound to chitin agarose beads. Enzyme **1** was produced by cleaving a truncated enzyme--intein fusion protein with 50 mM *N*-methylmercaptoacetamide (NMA) in the presence of peptide H-Cys-Sec-Gly-OH to effect ligation of the peptide to the thioester-tagged enzymes (Tables [2](#tbl2){ref-type="other"} and [3](#tbl3){ref-type="other"}).^[@ref19]^ Enzyme **2**, the Sec → Cys mutant of mTR, was produced using standard recombinant methods previously reported by us.^[@ref19]^ Cleavage of the truncated enzyme--intein fusion protein with either [l]{.smallcaps}-cysteine or [l]{.smallcaps}-homocysteine in the absence of NMA yielded enzymes **3** and **4**. [l]{.smallcaps}-Homocysteine was generated from a solution of [l]{.smallcaps}-homocystine (25 mM) dissolved in 50 mM MOPS buffer (pH 7.0) with 150 mM NaCl and 75 mM DTT. The pH of the solution was adjusted to 10 to improve the homocysteine solubility and then reduced to 7.9 for optimal cleavage of the enzyme from the intein. After incubation for 30 min, this cleavage buffer was added to the chitin resin-bound enzyme, and the mixture was gently agitated overnight at 4 °C. Enzyme **5** was produced by treating the mTR3Δ3--intein fusion protein with 50 mM [l]{.smallcaps}-selenocysteine. [l]{.smallcaps}-Selenocysteine was produced by reducing [l]{.smallcaps}-selenocystine with a 3-fold excess of sodium borohydride in water for 15 min. The excess sodium borohydride was quenched by addition of acetic acid, after which the solution was brought to pH 7.0 by addition of 500 mM potassium phosphate buffer. This solution was then immediately applied to the bound fusion protein on the chitin resin.

###### Selenocystine Reductase Activities of WT mTR3 and Mutant Enzymes

  enzyme         enzyme number   *k*~cat~ (min^--1^)                  *K*~m~ (μM)                          activity at 91 μM \[mol of NADPH min^--1^ (mol of enzyme)^−1^\]
  -------------- --------------- ------------------------------------ ------------------------------------ -----------------------------------------------------------------
  mTR-GCUG       **1**           1403.6 ± 128                         341.2 ± 59.0                         295 ± 20
  mTR-GCCG       **2**           681.7 ± 91.5                         791.3 ± 151.7                        78 ± 3
  mTR-G**C**     **3**           NA[a](#t2fn1){ref-type="table-fn"}   NA[a](#t2fn1){ref-type="table-fn"}   12.5 ± 2
  mTR-G**hC**    **4**           NA[a](#t2fn1){ref-type="table-fn"}   NA[a](#t2fn1){ref-type="table-fn"}   8 ± 1
  mTR-G**U**     **5**           NA[a](#t2fn1){ref-type="table-fn"}   NA[a](#t2fn1){ref-type="table-fn"}   176 ± 4
  mTR-GG**C**    **6**           NA[a](#t2fn1){ref-type="table-fn"}   NA[a](#t2fn1){ref-type="table-fn"}   12 ± 1
  mTR-GG**hC**   **7**           NA[a](#t2fn1){ref-type="table-fn"}   NA[a](#t2fn1){ref-type="table-fn"}   16 ± 0.1
  mTR-GG**U**    **8**           194.5 ± 7                            10.4 ± 2                             124 ± 9
  mTR-G          **9**           NA[a](#t2fn1){ref-type="table-fn"}   NA[a](#t2fn1){ref-type="table-fn"}   1.4 ± 0.2
  mTRΔ8          **10**          NA[a](#t2fn1){ref-type="table-fn"}   NA[a](#t2fn1){ref-type="table-fn"}   0.6 ± 0.1

Not applicable.

###### Trx-Reductase Activities of WT mTR3 and Mutant Enzymes

  enzyme         enzyme number   *k*~cat~ (min^--1^)                  *K*~m~ (μM)
  -------------- --------------- ------------------------------------ ------------------------------------
  mTR-GCUG       **1**           2220 ± 78                            67.6 ± 6
  mTR-GCCG       **2**           4 ± 0.1                              49 ± 3
  mTR-G**C**     **3**           ND[a](#t3fn1){ref-type="table-fn"}   ND[a](#t3fn1){ref-type="table-fn"}
  mTR-G**hC**    **4**           ND[a](#t3fn1){ref-type="table-fn"}   ND[a](#t3fn1){ref-type="table-fn"}
  mTR-G**U**     **5**           ND[a](#t3fn1){ref-type="table-fn"}   ND[a](#t3fn1){ref-type="table-fn"}
  mTR-GG**C**    **6**           ND[a](#t3fn1){ref-type="table-fn"}   ND[a](#t3fn1){ref-type="table-fn"}
  mTR-GGh**C**   **7**           4 ± 0.1                              42 ± 3
  mTR-GG**U**    **8**           11.6 ± 0.3                           8 ± 1
  mTR-G          **9**           ND[a](#t3fn1){ref-type="table-fn"}   ND[a](#t3fn1){ref-type="table-fn"}
  mTRΔ8          **10**          ND[a](#t3fn1){ref-type="table-fn"}   ND[a](#t3fn1){ref-type="table-fn"}

Not detectable.

The mTR3Δ3 fusion protein construct was modified to include an additional codon (GGT, Gly) between mTR3 and the intein--CBD fusion protein to give a mutant in which Cys~1~ was mutated to Gly, resulting in an mTR3Δ2 fusion construct. This construct was cleaved from the intein using either [l]{.smallcaps}-cysteine or [l]{.smallcaps}-homocysteine to generate enzymes **6** and **7**. Enzyme **8** was produced by treating the mTRΔ2--intein fusion protein with 50 mM selenocysteine using a procedure identical to that described for enzyme **5**.

Truncated mTR enzymes missing either the final three C-terminal amino acids or the final eight C-terminal amino acids, mTR3Δ3 or mTR3Δ8, respectively (enzyme **9** or **10**, respectively), were produced as reported by us previously.^[@ref19],[@ref25],[@ref30]^ All enzyme constructs were purified using hydrophobic and anion exchange chromatography as described previously.^[@ref19],[@ref25],[@ref30]^ After purified enzymes had been concentrated using ultrafiltration, homodimeric enzyme concentrations were determined by measuring the absorbance of flavin adenine dinucleotide (FAD) at 460 nm using an extinction coefficient of 11.3 mM^--1^ cm^--1^ and a stoichiometric ratio of 2 mol of FAD/mol of dimeric enzyme.

Enzymatic Assays of TR {#sec2.4}
----------------------

The assays for Trx, DTNB, and selenocystine as substrates of TR have been previously described.^[@ref6],[@ref19],[@ref24],[@ref25],[@ref30],[@ref37]^ Assay conditions for Trx with WT and mutant TRs consisted of 50 mM potassium phosphate buffer (pH 7.0) with 1 mM EDTA, 150 μM NADPH, and 170 μM bovine pancreatic insulin with varying concentrations of *E. coli* Trx. DTNB assays were conducted with 100 mM potassium phosphate buffer (pH 7.0), 10 mM EDTA, 200 μM NADPH, and various concentrations of DTNB. Assays with selenocystine as the substrate contained 500 mM potassium phosphate (pH 7.0), 10 mM EDTA, 200 μM NADPH, and various concentrations of selenocystine.

Br`ø`nsted Analysis of Aryl Disulfide Peptide Substrates {#sec2.5}
--------------------------------------------------------

Assays with arylthiol peptide substrates **I--IV** in Table [1](#tbl1){ref-type="other"} contained 100 mM potassium phosphate (pH 7.0), 1 mM EDTA, 150 μM NADPH, and various concentrations of peptide substrates (between 50 and 2000 μM). The assay was initiated by the addition of 96.4 nM mTR3Δ8. The rate constant was calculated as the slope from a plot of the rate of the reaction (micromolar per minute) versus substrate concentration. A Br`ø`nsted plot was then constructed by plotting the log of the rate constant versus the p*K*~a~ of the thiol of the peptide substrate.

Results and Discussion {#sec3}
======================

Brønsted Analysis of Mixed Aryl-Peptide Disulfide Substrates Does Not Support the Leaving Group Model {#sec3.1}
-----------------------------------------------------------------------------------------------------

To assess whether our original Se as a leaving group model was correct for the thiol/disulfide exchange reaction shown in Figure [1](#fig1){ref-type="fig"}B, we assayed enzyme mTR3Δ8, which lacks the C-terminal redox motif, for activity using synthesized mixed aryl-peptide disulfide substrates. The aryl group contained a *para* substituent that allowed for variability of the arylthiol p*K*~a~ in the range of 5.7--6.6 (the atom labeled S~2~ in Figure [2](#fig2){ref-type="fig"}). The advantage of the experimental design shown in Figure [2](#fig2){ref-type="fig"} is that it allows for the study of the kinetics of the thiol/disulfide exchange step that occurs between N- and C-terminal redox centers. We refer to this step simply as "the exchange step" hereafter.

![Strategy for isolating the exchange step in the reaction mechanism. Our previous studies as well as this study make use of a truncated enzyme missing the C-terminal redox center in conjunction with small molecule substrates to gain a better understanding of the exchange step in the mechanism (represented by rate constant *k*~ex~). Here, we have constructed peptides in which Sec~2~ is replaced with a *para*-substituted arylthiol group that allows us to alter the p*K*~a~ of S~2~ of the product, to measure the dependency of *k*~ex~ on leaving group p*K*~a~.](bi-2013-00658g_0003){#fig2}

The structure, p*K*~a~ values, and specific disulfide-reductase activities for these peptide substrates (**I--IV**) using mTR3Δ8 as the enzyme catalyst are given in Table [1](#tbl1){ref-type="other"}. We note that although we used the symbol *k*~ex~ to denote the individual rate constant of the exchange step in Figure [2](#fig2){ref-type="fig"}, we did not make this measurement. Rather, we report a specific disulfide-reductase activity in Table [1](#tbl1){ref-type="other"}, which is a composite of all of the individual steps on the path needed to generate the product of the reaction.

However, a rate constant for each peptide substrate was determined by plotting the rate of the steady-state reaction (micromolar per minute) versus peptide concentration (micromolar). The slope of the resulting plot yielded the rate constant *k*. A plot of log *k* versus p*K*~a~ (Br`ø`nsted plot) shows that the rate increases with an increase in p*K*~a~ as shown in Figure [3](#fig3){ref-type="fig"}. The slope of the line in this plot is the Br`ø`nsted coefficient, β, and has a value of 1.1. A high, positive value of β such as this is interpreted to mean either that there is positive charge on S~2~ in the transition state or that there is a loss of negative charge on S~2~ in the transition state.^[@ref42]^ These data do not support the Se as a leaving group model. If the exchange step in Figure [1](#fig1){ref-type="fig"}B was dominated by the need for a low-p*K*~a~ leaving group, the Br`ø`nsted coefficient in Figure [3](#fig3){ref-type="fig"} would be large and negative (i.e., −1). The fact that the experimentally determined value of β was large and positive is interpreted by us to mean that the -S~1~--S~2~- bond becomes highly polarized in the transition state, with electron density moving away from S~2~ toward S~1~ of the arylthiol peptide substrate. If the aryl-peptide disulfide substrates are accepted as a reasonable model for the C-terminal redox center of the enzyme, this would mean that in the native enzyme the -S--Se- bond becomes polarized to allow the Se atom to accept electrons more easily from Cys~IC~ during the exchange step. Thus, the analysis of the Br`ø`nsted data supports the Se as an electrophile model mentioned in the introductory section. We note that our analysis assumes that dissociation of both products that result from cleavage of the disulfide bond of the aryl-peptide disulfide substrate is not too dissimilar from the dissociation of the C-terminal redox center that is covalently bound to the enzyme. As discussed in the next section, the concept of bond polarization can explain why some disulfides can be used as substrates by the N-terminal redox center and others cannot.

![Br`ø`nsted plot for the truncated enzyme with peptide disulfide substrates. The plot shows that over this range of p*K*~a~ values, high disulfide reductase activity is correlated with increase in thiol p*K*~a~ with a Br`ø`nsted coefficient of 1.1 (slope). The position of peptide **IV** is indicated by the arrow.](bi-2013-00658g_0004){#fig3}

In the Absence of Se, Some Disulfides Are Good Substrates for the N-Terminal Redox Center: An Explanation {#sec3.2}
---------------------------------------------------------------------------------------------------------

A good example illustrating how bond polarization (electrophilicity) can accelerate the rate of the exchange reaction between the N-terminal redox center of mTR3Δ8 and disulfide substrates is the comparison of two *symmetric*, linear disulfides such as DTNB and cystine. The disulfide bond of DTNB is highly polarized (activated) because of the attachment of strong, symmetrical electron-withdrawing nitroaryl groups and is turned over 11--14-fold faster than peptides **IV** and **V** (Table [1](#tbl1){ref-type="other"}). Symmetrical, nonpolarized disulfides, such as cystine, are extremely poor substrates for the truncated enzyme. For the purposes of direct comparison, the activity of mTR3Δ8 toward 200 μM DTNB is 420 mol of NADPH min^--1^ (mol of enzyme)^−1^, while at the same concentration of cystine, the activity is 0.1 mol of NADPH min^--1^ (mol of enzyme)^−1^, a 4200-fold difference.

The Se as a leaving group model predicted that mTR3Δ8 would reduce peptide **IV** (highest p*K*~a~) with the slowest rate and peptide **I** (lowest p*K*~a~) with the fastest rate. The opposite result was found experimentally (Table [1](#tbl1){ref-type="other"}). The mTR3 enzyme has nearly 24-fold higher activity with peptide **IV** than with peptide **II**, in which the arylthio group has a p*K*~a~ that is lower by 0.65 p*K* units. In fact, the activity with peptide **IV** was nearly as high as that with peptide **V**, which contains the "native", vicinal selenosulfide bond, identical to that which is found in the C-terminal tail of the enzyme (the result with **V** was originally reported in ref ([@ref25])).

Upon closer inspection of the structure of **IV**, we realized that it can mimic the physicochemical properties of the native peptide **V** in two ways. First, peptide **IV** can be held rigidly in the active site, just as is true for any substrate that is efficiently turned over in a typical enzyme active site. We suggest that the reason for peptide **IV** being rigidly held is that the *p*-carboxylate group is the "correct" distance from S~2~, allowing it to form an ionic interaction with a basic group on the enzyme as shown in Figure [4](#fig4){ref-type="fig"}. The geometric similarity between **IV** and the native peptide is further explained in the legend of Figure [5](#fig5){ref-type="fig"}. Even though **IV** is a linear disulfide, the ability to be held rigidly in the active site would mimic the geometry of the eight-membered ring in the native peptide. Second, the S~1~--S~2~ bond is polarized because of the presence of the *para*-substituted aryl group and would be further polarized if S~1~ were near a positive charge in the active site, such as His463′,[a](#fn2){ref-type="fn"} which acts as an acid/base catalyst during the enzymatic reaction cycle. Both of these factors would help to make S~2~ electron deficient (make S~2~ electrophilic) and accelerate the thiol/disulfide exchange reaction between the N-terminal redox center and the substrate.

![Peptide **IV** can be held rigidly in the active site and activated for the exchange reaction. The correct placement of the peptide disulfide in **IV** relative to the N-terminal active site could serve to "electrophilically activate" the disulfide for attack by Cys~IC~ by positioning atom S~1~ of the disulfide near the positively charged imidazolium group of His463′, inducing a strong polarization in the disulfide bond of **IV**. This polarization would be made possible by tight binding of the substrate in the active site because of an interaction between the negatively charged phenylacetate group (colored red) and a basic group on the enzyme (colored green). The basic group on the enzyme has been predicted to be either Lys29 in the rat TR1 structure (equivalent to Lys29 in the mouse TR3 enzyme) or Arg351 in a model of the human TR--Trx complex structure (equivalent to Arg342 in the mouse TR3 enzyme).^[@ref43],[@ref44]^ This suggests how a similar exchange reaction is accelerated in the Cys ortholog. For the sake of simplicity, we do not show the interaction between FAD and NADP^+^.](bi-2013-00658g_0005){#fig4}

![We note that the distance between S~2~ of the disulfide of **IV** and the carboxylate group (colored red) is similar to the distance between the Se atom of the native peptide and the C-terminal carboxylate group (five intervening carbon atoms). This similarity could further explain why the disulfide of **IV** is turned over at a rate similar to that of the selenosulfide of peptide **V**. This is also similar to the distance between the carboxylate group of lipoic acid and the sulfur atom of the ring. We have shown previously that lipoic acid is a surrogate substrate for the C-terminal redox center.^[@ref6]^ This structural similarity of the various substrates is underscored by the evolutionary relationship between TR and lipoamide dehydrogenase, another pyridine nucleotide disulfide oxidoreductase that reduces lipoyl-disulfide groups.](bi-2013-00658g_0006){#fig5}

The correct active site geometry is not the only requirement for disulfide substrates to be turned over by mTR3Δ8 because peptide **VII** meets the same distance criteria between S~2~ and the C-terminal carboxylate as peptide **IV** (both asymmetric, linear disulfides). However, **IV** is turned over ∼4500-fold faster than **VII** by mTR3Δ8. This large difference in rate acceleration can be explained if the -S~1~--S~2~- disulfide bond of **IV** is highly polarized as we posit. If the S atom of **VII** is removed and replaced by Se as is the case for **VIII**, the rate increases 225-fold. This latter number is in the range of the fold decrease in activity when Sec is mutated to Cys in TR and other selenoenzymes.^[@ref20],[@ref45]^ A reasonable conclusion from these data is that Se confers polarization to a -S--Se- bond, and this bond polarization is responsible for the acceleration of the rate in **VIII** compared to that in **VII**.

Further support for this polarization hypothesis is given by comparing the turnover rates of peptide substrates in Table [1](#tbl1){ref-type="other"} that differ by only a single feature. For example, the **V**:**VI** turnover ratio shows that bond polarization contributes a factor of ∼2000 to rate acceleration. Comparison of the activities of **V/VIII** and **VII/VIII** pairs implies that a combination of correct distance and geometry contributes a factor of 10--25 to the exchange rate, while polarization (electrophilicity) contributes a factor of 200 for the mammalian enzyme. Please note that peptides **VI** and **VII** are both turned over at nearly the same slow rate, which shows the dramatic effect that the loss of polarization in the disulfide bond caused by substitution of S for Se has on the exchange step. This analysis of the data in Table [1](#tbl1){ref-type="other"} supports the Se as an electrophile model and supports path 2 as being the correct pathway for the exchange reaction shown in Figure [1](#fig1){ref-type="fig"}B.

Functional Assay for Assessing Peptide Incorporation in IPL {#sec3.3}
-----------------------------------------------------------

Enzymes **3--8** were constructed by using IPL.^[@ref46]^ This method allows us to incorporate Sec, hCys, and other non-natural amino acids into TR to investigate the function of the C-terminal redox center as done here and reported by us previously.^[@ref19],[@ref24],[@ref30]^ IPL usually involves ligation of a peptide containing an N-terminal Cys, Sec, or hCys residue to a thioester-tagged protein.^[@ref46]^ However, here we are using a *single* amino acid instead of a peptide to achieve the same goal. The use of Cys, Sec, or hCys as a cleavage/ligation reagent results in the addition of a single amino acid to the C-terminal end of mTR3 as shown in Figure [6](#fig6){ref-type="fig"}A. One possible side reaction of the thioester is hydrolysis, which would result in protein eluting from the column without the addition of the added amino acid. To test whether cleavage of the thioester-tagged TR was due to the addition of amino acid rather than hydrolysis of the thioester, a control experiment was performed for enzymes **3--8** to measure the amount of cleavage in the absence of an amino acid from the cleavage buffer. These experiments yielded an eluent from the chitin column with no measurable selenocystine-reductase activity, which is evidence that little or no hydrolysis of the thioester occurs during incubation with the cleavage buffer containing the single amino acid.

![Selenocystine-reductase activity of mTR3 as a semiquantitative measure of ligation efficiency. (A) The truncated enzyme lacking the Cys~1~-Sec~2~ dyad has very low selenocystine-reductase activity as reported by us previously.^[@ref6]^ In the experiments reported here, we constructed mutants containing a single redox-active residue (Cys, hCys, or Sec) by using these amino acids as reagents that would simultaneously undergo a transthiolesterification reaction with the thioester-tagged mTR3 enzyme produced as an intein fusion protein and subsequently become ligated to the C-terminal end. Cleavage of mTR3Δ3 with either Cys, hCys, or Sec results in the production of enzyme **3**, **4**, or **5**, respectively (Table [2](#tbl2){ref-type="other"}). Similarly, cleavage of mTR3Δ2 with either Cys, hCys, or Sec results in the production of enzyme **6**, **7**, or **8**, respectively. All of these enzymes have significantly higher selenocystine-reductase activity than the truncated enzyme (Table [2](#tbl2){ref-type="other"}), demonstrating that cleavage and ligation were successful. (B) The truncated enzyme cannot reduce selenocystine because of an apparent lack of ability of the N-terminal redox center to catalyze this reduction. (C) Reduction of selenocystine by mTR3 can be achieved with either a fully intact C-terminal redox center as in the case of enzymes **1** and **2** or a partially intact C-terminal redox center containing only a single redox-active residue (enzymes **3--8**). While we do not know complete mechanistic details for certain, the most likely explanation is that the C-terminal redox center is required for initiating attack on the substrate diselenide bond.](bi-2013-00658g_0007){#fig6}

In ligation experiments of the type performed here, it is desirable to achieve complete ligation of the peptide (amino acid) to the thioester-tagged protein. To test the efficiency of the ligation of the amino acid to thioester-tagged mTR3, we have devised an assay that allows us to make a semiquantitative assessment of ligation efficiency as shown in panels B and C of Figure [6](#fig6){ref-type="fig"}. This assay uses the reduction of selenocystine as an alternative substrate in place of Trx. We have previously reported that the Sec → Cys mutant of mitochondrial TR and any variant in which the C-terminal redox center contains either a sulfhydryl or selenol, as is the case with enzymes **3--8**, will reduce selenocystine as the data in Table [2](#tbl2){ref-type="other"} shows.^[@ref6]^ Thus, this assay becomes a simple test that allowed us to determine whether the C-terminal amino acid that we added in the cleavage buffer is present. If the amino acid were not ligated to the enzyme, the mutant should have selenocystine reductase activity similar to that of the truncated enzyme (enzyme **10**). The data in Table [2](#tbl2){ref-type="other"} indicate that the cleavage/ligation procedure was successful in adding Cys, Sec, or hCys to the C-terminus of TR. A second conclusion that can be drawn from the data in Table [2](#tbl2){ref-type="other"} is that enzymes **3--8**, with only partially intact C-terminal redox centers, are able to catalyze the same two thiol/disulfide exchange reactions that are shown in panels A and B of Figure [1](#fig1){ref-type="fig"} except that selenocystine has replaced Trx as the substrate. As discussed in the next section, only enzymes **7** and **8** can also reduce Trx.

Evidence That Selenium both Donates and Accepts Electrons in the Trx-Reductase Mechanism {#sec3.4}
----------------------------------------------------------------------------------------

The selenium atom of TR acts as the electron donor to the disulfide bond of Trx in both the selenium as a leaving group model (path 1 in Figure [1](#fig1){ref-type="fig"}B) and the selenium as an electrophile model (path 2 in Figure [1](#fig1){ref-type="fig"}B). We therefore predicted that a mutant of mTR3 containing only a single Sec residue in the C-terminal redox center would have Trx-reductase activity only if the single Sec residue was in the second position of the C-terminal Cys~1~-Sec~2~ redox dyad and selenium acted as the acceptor of electrons from the N-terminal redox center.[b](#fn3){ref-type="fn"} This prediction was tested by creating mutant enzymes **5** and **8** and assaying these enzymes for Trx-reductase activity. As can be seen by the data listed in Table [3](#tbl3){ref-type="other"}, while enzyme **8** has only 0.5% of the Trx-reductase activity of the WT enzyme, it has more than twice the Trx-reductase activity as the Sec → Cys mutant of mTR3 (enzyme **2**). Enzyme **5** has no detectable Trx-reductase activity in comparison. This experimental result provides strong evidence for the selenium as an electrophile model and also confirms the role of selenolate as the electron donor to substrate provided by the X-ray crystal structure of the mutant TR--Trx complex.^[@ref21]^

As a further test of this hypothesis, we also considered whether selenolate could be acting as a leaving group in the mixed selenosulfide bond of the TR--Trx complex in mutant enzyme **8**. In such a case, the thiolate of Cys~IC~ would attack the sulfur atom of the mixed selenosulfide bond and the reaction in mutant **8** would be fast relative to that with mutant **6** because of the superior leaving group ability of selenium. This possibility was tested by replacing each residue of the Cys~1~-Sec~2~ redox dyad with homocysteine (hCys, hC), while leaving the other position vacant to create mutants **4** and **7**, respectively. These two mutants are analogous to mutants **5** and **8** in design and construction. The thiolates of the Cys and hCys residues should have identical leaving group abilities and have similar nucleophilic character. A key difference is that the introduction of a hCys residue lengthens the distance between Cα and the sulfur atom by ∼3 Å relative to Cys. This added side chain length and flexibility should make the sulfur atom of hCys more accessible to the thiolate of Cys~IC~ for attack in a mixed disulfide complex between mutant TR and Trx. The results show that Trx-reductase activity is only present when the second position of the dyad is replaced with hCys \[enzyme **7** (Table [3](#tbl3){ref-type="other"})\]. This result confirms that the second position of the redox dyad is responsible for both accepting electrons from the N-terminal redox center and donating electrons to the substrate, whether it be a selenium atom of the Sec residue in the WT enzyme or the sulfur atom of the hCys residue in the mutant enzyme as shown in Figure [7](#fig7){ref-type="fig"}. We note that neither enzyme **3** nor enzyme **6** has Trx-reductase activity.

![Partial mechanism for WT TR and mutant enzymes **7** and **8**. Because of space considerations, we begin our depiction of the mechanism with the EH~4~ form of the enzyme and omit interactions between FAD and NADPH/NADP^+^ as occurs in the enzyme. Please see ref ([@ref14]) for a more detailed and complete description of the mechanism and electron flow from NADPH to the substrate. (A) The selenolate of the WT enzyme attacks the disulfide bond of Trx, forming a mixed selenosulfide bond between the enzyme and substrate (left). The mixed selenosulfide bond is then attacked by a resolving Cys residue, labeled as Cys~1~ of the Cys~1~-Sec~2~ dyad (middle). The resolution step results in the formation of a unique eight-membered ring structure that must be "opened" for the catalytic cycle to begin again (right). Our data, based on mutant enzymes **7** and **8**, indicate that it is the Se atom of the ring that is attacked by the thiolate of Cys~IC~ (interchange Cys). (B) Enzyme **8** was able to reduce Trx at a rate higher than that of the Sec → Cys mutant (enzyme **2**) but lacks the resolving Cys residue (Cys~1~) so that a ring formation pathway is impossible with this mutant. As shown above, the mechanism must bypass this ring-closing step and resolution of the mixed selenosulfide bond must be conducted by the thiolate of Cys~IC~. (C) Mutant enzyme **7** contains only a single sulfhydryl group in the C-terminal redox center and, similar to enzyme **8**, can still reduce Trx. Mutant enzyme **7**, like enzyme **8**, must avoid a pathway that involves ring formation and instead rely on the thiolate of Cys~IC~ for the resolution step. Both of these results provide strong evidence that the residue in the second position of the C-terminal dyad of the mammalian enzyme (Sec) is responsible for both accepting and donating electrons. The Sec residue accepts electrons from the N-terminal redox center and then donates them to the substrate, Trx.](bi-2013-00658g_0008){#fig7}

Conclusion {#sec4}
==========

This study has provided the first experimental evidence that the selenium atom is attacked in a "thiol/disulfide-like" exchange reaction in which Se replaces S.^[@ref48]^ Our data show that Se is responsible for both donating and accepting electrons during the catalytic cycle of mammalian TR and that the role of Se as an electron acceptor should be given consideration as a way in which Se helps to accelerate enzymatic reactions.
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Cys

:   cysteine

Cys~CT~

:   charge-transfer Cys

Cys~IC~

:   interchange cysteine

DEAE

:   diethylaminoethyl

DTNB

:   5,5′-dithiobis(2-nitrobenzoic acid)

DTT

:   dithiothreitol

EDTA

:   ethylenediaminetetraacetic acid

Gly

:   glycine

hCys

:   homocysteine

IPL

:   intein-mediated peptide ligation

*M*~r~

:   molecular ratio

mTR3

:   mitochondrial TR from mouse

NADPH

:   reduced β-nicotinamide adenine dinucleotide phosphate

NMA

:   *N*-methylmercaptoacetamide

Sec

:   selenocysteine

Ser

:   serine

TB

:   Terrific Broth

TR

:   thioredoxin reductase

Tris

:   tris(hydroxymethyl)aminomethane

Trx

:   thioredoxin

U

:   one-letter code for Sec

WT

:   wild-type.

The prime designation denotes amino acids that are part of the B-chain. The N- and C-terminal redox centers are on opposite subunits of the head-to-tail dimer.

We note that there are large differences in the catalytic mechanisms of the cytosolic TR1 enzyme and the mitochondrial TR3 enzyme as reported in ref ([@ref47]). As a result of these differences, the experiments performed here may not have been possible with TR1. Even so, results from the X-ray crystal structures of TR1 and TR3 show that attack at the selenium atom of the selenosulfide is the most likely path^[@ref22],[@ref23]^ as the data here show. All of our work on the TR reaction mechanism has been with the mitochondrial form of the enzyme, and only recently have we begun to appreciate differences in reaction mechanism between the two types. For example, the selenocystine-reductase activity of the Cys mutant of mTR3 is high,^[@ref6]^ while for the cytosolic enzyme, this activity is very low.^[@ref20]^
